FDA’s Center for Biologics Evaluation and Research, Office of Therapeutic Products, will hold a
virtual workshop Feb. 25 focused on generating scientific evidence to facilitate the development of cell therapies (CTs) and tissue-based products. The event will examine the current state of science, development and regulation in these fields.
The workshop will take place virtually from 8:30 a.m. to 5 p.m. ET.
Registration is complimentary but required to attend. The agency will post a program agenda closer to the date of the workshop.
